Suchergebnisse - "Sarilumab"

PubPharm (81)

31

Pharmacokinetics and Pharmacodynamics of Subcutaneous Sarilumab and Intravenous Tocilizumab Following Single-Dose Administration in Patients With Active Rheumatoid Arthritis on Stable Methotrexate

enthalten in: Journal of clinical pharmacology | 2021

von Paccaly, A. | Kovalenko, P. | Parrino, J. | +6

32

Population Pharmacokinetic-Pharmacodynamic Relationships of Sarilumab Using Disease Activity Score 28-Joint C-Reactive Protein and Absolute Neutrophil Counts in Patients with Rheumatoid Arthritis

enthalten in: Clinical pharmacokinetics | 2020

von Ma, L. | Xu, C. | Paccaly, A. | +1

33

High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab

enthalten in: Arthritis research & therapy | 2020

von Strand, V. | Boklage, S. | Kimura, T. | +3

34

Association of High Serum Interleukin-6 Levels With Severe Progression of Rheumatoid Arthritis and Increased Treatment Response Differentiating Sarilumab From Adalimumab or Methotrexate in a Post Hoc Analysis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2020

von Boyapati, A. | Schwartzman, S. | Msihid, J. | +9

35

Investigational Therapies for the Treatment of COVID-19 : Updates from Ongoing Clinical Trials

enthalten in: European urology focus | 2020

von Abrams-Downey, A. | Saabiye, J. | Vidaurrazaga, M.

36

Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes : post hoc analyses of three randomised, controlled trials

enthalten in: Arthritis research & therapy | 2020

von Genovese, M. | Burmester, G. | Hagino, O. | +6

37

Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure

enthalten in: BMJ open respiratory research | 2020

von Patel, M. | Gangemi, A. | Marron, R. | +14

38

Population Pharmacodynamic Model of Neutrophil Margination and Tolerance to Describe Effect of Sarilumab on Absolute Neutrophil Count in Patients with Rheumatoid Arthritis

enthalten in: CPT: pharmacometrics & systems pharmacology | 2020

von Kovalenko, P. | Paccaly, A. | Boyapati, A. | +6

39

Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs : a population-based study

enthalten in: Annals of the rheumatic diseases | 2020

von Salvarani, C. | Bajocchi, G. | Mancuso, P. | +17

CommentIn: Ann Rheum Dis. 2021 Jun;80(6):e96. - PMID 32632030

40

Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studies

enthalten in: Arthritis research & therapy | 2020

von Genovese, M. | Fleischmann, R. | Kivitz, A. | +6